1. SeaSpine, SI-Bone, Zimmer Biomet, NuVasive, Alphatec and Smith+Nephew all posted their second quarter financial results.
2. Orthofix’s M6-C artificial disc is being evaluated for contiguous two-level symptomatic cervical radiculopathy. Todd Lanman, MD, implanted the first device in the study.
3. Aurora Spine received 510(k) approval from the FDA for its Dexa-C cervical interbody system.
4. King of Prussia, Pa.-based medical device company Camber Spine got a green light from the FDA for two of its lumbar spacer products, the SPIRA-P and SPIRA-T.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
